Prime Medicine Inc (PRME)
3.345
-0.25
(-6.95%)
USD |
NASDAQ |
Nov 15, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Shareholders Equity (Quarterly): 189.50M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 189.50M |
| June 30, 2024 | 196.59M |
| March 31, 2024 | 243.77M |
| December 31, 2023 | 133.07M |
| September 30, 2023 | 193.96M |
| June 30, 2023 | 240.10M |
| Date | Value |
|---|---|
| March 31, 2023 | 278.80M |
| December 31, 2022 | 316.27M |
| September 30, 2022 | 172.70M |
| June 30, 2022 | 200.74M |
| December 31, 2021 | 239.56M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
133.07M
Minimum
Dec 2023
316.27M
Maximum
Dec 2022
218.64M
Average
200.74M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 17.14B |
| Molecular Templates Inc | 7.111M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 332.78M |
| Total Liabilities (Quarterly) | 143.28M |
| Current Ratio | 6.497 |